Habib S L. Diabetes and renal tubular cell apoptosis[J]. World J Diabetes, 2013, 4(2): 27-30.？ [2]Flyvbjerg A. Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily[J]. Nat Rev Endocrinol, 2010, 6(2): 94-101.？ [3]Candido R. The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney[J]. Curr Opin Nephrol Hypertens, 2014, 23(1): 69-74.？ [4]Tervaert T W, Mooyaart A L, Amann K, et al. Pathologic classification of diabetic nephropathy[J]. J Am Soc Nephrol, 2010, 21(4): 556-563.？ [5]Okada T, Nagao T, Matsumoto H, et al. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria[J]. Nephrology (Carlton), 2012, 17(1): 68-75.？ [6]Ninichuk V, Kulkarni O, Clauss S, et al. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy[J]. Eur J Med Res, 2007, 12(8): 351-355.？ [7]Bagby S P. Diabetic nephropathy and proximal tubule ROS: challenging our glomerulocentricity[J]. Kidney Int, 2007, 71(12): 1199-1202.？ [8]Najafian B, Mauer M. Morphologic features of declining renal function in type 1 diabetes[J]. Semin Nephrol, 2012, 32(5): 415-422.？ [9]Lorz C, Benito-Martin A, Boucherot A, et al. The death ligand TRAIL in diabetic nephropathy[J]. J Am Soc Nephrol, 2008, 19(5): 904-914. [10]Sagiv A, Biran A, Yon M, et al. Granule exocytosis mediates immune surveillance of senescent cells[J]. Oncogene, 2013, 32(15): 1971-1977.？ [11]Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 300(5): R1009-R1022.？ [12]Bernardi S, Norcio A, Toffoli B, et al. Potential role of TRAIL in the management of autoimmune diabetes mellitus[J]. Curr Pharm Des, 2012, 18(35): 5759-5765.？ [13]Chen K, Zhang J, Zhang W, et al. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy[J]. Int J Biochem Cell Biol, 2013, 45(5): 932-943.？ [14]Mi Q S, Ly D, Lamhamedi-Cherradi S E, et al. Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice[J]. Diabetes, 2003, 52(8): 1967-1975.？ [15]陈兵, 张燕, 柳刚, 等.缬沙坦联合霉酚酸酯对糖尿病大鼠肾脏TRAIL及NF-κB的影响[J]. 中华医学杂志, 2008, 88(8): 540-545. [16]Nguyen V, Cudrici C, Zernetkina V, et al. TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects[J]. Clin Immunol, 2009, 132(1): 32-42.？ [17]Azijli K, Weyhenmeyer B, Peters G J, et al. Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family[J]. Cell Death Differ, 2013, 20(7): 858-868.
